Covidien (COV +0.2%) received a warning letter from the FDA earlier this month about the...

|By:, SA News Editor

Covidien (COV +0.2%) received a warning letter from the FDA earlier this month about the manufacturing of surgical staples and single-use loading units at the company's North Haven facility in Connecticut. The agency said Covidien's response in February to its concerns was inadequate.